$BIIB News Biogen Idec investors focus on

New Post Public Reply Private Reply Replies (0) Message Board

Feb 4, 2014 at 9:50 AM

$BIIB News

Biogen Idec investors focus on positive, ignore outlook for 2014

2:02 p.m. Jan. 29, 2014
- blogs.marketwatch.com

Biogen profit jumps on MS treatment revenue
7:09 a.m. Jan. 29, 2014
- MarketWatch.com

Stock investors trash market darlings, face Apple, Fed
8:00 a.m. Jan. 26, 2014
- Wallace Witkowski

The market puts a few feathers in its cap
1:58 p.m. Jan. 23, 2014
- The Trading Deck

Speculators turn the heat up to ‘soft boil’
3:54 p.m. Jan. 16, 2014
- The Trading Deck

GameStop tumbles 20%; Tesla surges on strong sales
4:22 p.m. Jan. 14, 2014
- Ben Eisen

Beam up on Suntory deal; Elliott report lifts Juniper
4:17 p.m. Jan. 13, 2014
- Saumya Vaishampayan

Biogen, Sangamo partner on hemoglobin therapies
9:38 a.m. Jan. 9, 2014
- MarketWatch.com

Earnings boost Micron, drag on Container Store
4:24 p.m. Jan. 8, 2014
- Ben Eisen

Goldman's biotech downgrade and the new consensus
11:53 a.m. Jan. 6, 2014
- MarketWatch.com

Charting a bullish year-end backdrop
12:28 p.m. Dec. 17, 2013
- Michael Ashbaugh

Charting a bullish year-end backdrop
12:03 p.m. Dec. 17, 2013
- Michael Ashbaugh

Get your portfolio to turn the corner
2:32 p.m. Dec. 10, 2013
- The Trading Deck

Speculators should retain a flexible approach
1:41 p.m. Dec. 4, 2013
- The Trading Deck

Growth stock players should reduce expectations
1:18 p.m. Nov. 26, 2013
- The Trading Deck

DaVita, Fresenius gain; energy firms slip
4:55 p.m. Nov. 25, 2013
- Ben Eisen

Stocks gain for 7th week; S&P ends above 1,800
4:24 p.m. Nov. 22, 2013
- Polya Lesova

Biogen Idec jumps; Intel, Ross Stores slide
4:23 p.m. Nov. 22, 2013
- Ben Eisen

Biogen surges 13%, best on S&P 500
9:33 a.m. Nov. 22, 2013
- Laura Mandaro

The Four Horsemen send a message
12:46 p.m. Nov. 13, 2013
- The Trading Deck

Dear Healthcare Investors: The Correction, It's Here

5:16 a.m. Today5:16 a.m. Feb. 4, 2014
- Seeking Alpha

Guidance Update From Actavis - Analyst Blog

5:40 p.m. Feb. 3, 2014
- Zacks.com

Biogen Idec Inc (BIIB): Today's Featured Health Care Laggard

5:01 p.m. Feb. 3, 2014
- TheStreet.com

Big Cap 20 Leaders Hang In There Despite Unsettled Market

4:52 p.m. Feb. 3, 2014
- Investors Business Daily

Biogen In Buy Range, Wins EU Approval For Tecfidera

3:34 p.m. Feb. 3, 2014
- Investors Business Daily

InterMune (ITMN) in Focus: Stock Tumbles 17.9% - Tale of the Tape

8:43 a.m. Feb. 3, 2014
- Zacks.com

Biogen Idec Inc. (BIIB): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report

7:00 a.m. Feb. 3, 2014
- Zacks.com

China Biotech In Review: Mindray Acquires Control Of U.S.-China IVD Company

3:54 a.m. Feb. 2, 2014
- Seeking Alpha

Biotech Sector Performance January 2014 Strong, but What's Ailing Celgene?

2:12 p.m. Jan. 31, 2014
- TheStreet.com

Zacks Rank #1 Additions for Friday - Tale of the Tape

9:30 a.m. Jan. 31, 2014
- Zacks.com

Facebook Tops 5 Leaders With Rising Profit Estimates

8:00 a.m. Jan. 31, 2014
- Investors Business Daily

Jefferies Says Buy Any Pullback on Top Focus Stocks for Big Gains
7:22 a.m. Jan. 31, 2014
- 247WallSt.com

Biogen Idec Is a Buy Idea

12:09 a.m. Jan. 31, 2014
- Barrons.com

Celgene -2.2% after earnings, NEJM report, while other big biotechs surge

2:44 p.m. Jan. 30, 2014
- Seeking Alpha

FDA Nod for New Formulation of Teva's Copaxone - Analyst Blog

5:10 p.m. Jan. 29, 2014
- Zacks.com

Biogen's Report Sends Stock Up; Other Biotechs Follow

5:01 p.m. Jan. 29, 2014
- Investors Business Daily

Will Affymetrix (AFFX) Surprise This Earnings Season? - Analyst Blog

4:30 p.m. Jan. 29, 2014
- Zacks.com

Biogen Beats, Tecfidera Continues to Shine - Analyst Blog

1:32 p.m. Jan. 29, 2014
- Zacks.com

Biogen MS Drug Tecfidera Outperforms; Outlook Light

10:41 a.m. Jan. 29, 2014
- Investors Business Daily

Facebook, Biogen, Sands Among Top Big Caps Reporting

7:02 a.m. Jan. 29, 2014
- Investors Business Daily

Cleave Biosciences Names Alessandra Cesano as Chief Medical Officer and Lewis Shuster as Director
8:00 a.m. Today8:00 a.m. Feb. 4, 2014
- PR Newswire - PRF

TECFIDERA® (Dimethyl Fumarate) Approved in
the European Union as a First-Line Oral Treatment for Multiple Sclerosis
9:33 a.m. Feb. 3, 2014
- BusinessWire - BZX

TECFIDERA® (Dimethyl Fumarate) Approved in
the European Union as a First-Line Oral Treatment for Multiple Sclerosis
8:53 a.m. Feb. 3, 2014
- BusinessWire - BZX

RBCC: 3D Bioprinting Tech Ushers in Future of Medicine
8:40 a.m. Feb. 3, 2014
- BusinessWire - BZX

Ignyta Appoints Matthew Onaitis as General Counsel
7:00 a.m. Feb. 3, 2014
- BusinessWire - BZX

Biogen Idec Foundation Awards Museum of Science $2.5 Million to
Support Hall of Human Life
8:30 a.m. Jan. 30, 2014
- BusinessWire - BZX

Biogen Idec and UCB Enter Agreements to Commercialize Multiple
Sclerosis and Hemophilia Therapies in Asia
1:00 a.m. Jan. 30, 2014
- BusinessWire - BZX

Biogen Idec 2013 Total Revenues Increase 26 Percent to $6.9 Billion
6:30 a.m. Jan. 29, 2014
- BusinessWire - BZX

RBCC Develops Innovations in White-Hot 3D Bioprinting Sector
4:00 a.m. Jan. 27, 2014
- BusinessWire - BZX

RXI Pharmaceuticals Could Benefit from Biotech Industry Dynamics
10:06 a.m. Jan. 24, 2014
- ACCESSWIRE

Critical Alerts For General Electric, SodaStream, Biogen Idec, Linn Energy, and Allscripts Released By InvestorsObserver
9:31 a.m. Jan. 24, 2014
- PR Newswire - PRF

RBCC Moves to the Front Lines of the 3D Bioprinting Revolution
5:00 a.m. Jan. 20, 2014
- BusinessWire - BZX

RBCC Prepares Big Push Into Booming 3D Bioprinting Market
5:00 a.m. Jan. 16, 2014
- BusinessWire - BZX

Biogen Idec to Report Fourth Quarter and Year-End 2013 Financial
Results on January 29, 2014
4:01 p.m. Jan. 15, 2014
- BusinessWire - BZX

RBCC Partner Therakine Presents Novel Drug Delivery Technology at
Biotech Showcase
5:00 a.m. Jan. 15, 2014
- BusinessWire - BZX

Biogen Idec Announces Availability of FAMPYRA® in
Ireland to Treat Walking Impairment in Adults with Multiple Sclerosis
4:00 a.m. Jan. 15, 2014
- BusinessWire - BZX

Leading Life Sciences CEOs Honor Johnson & Johnson Chief Scientific
Officer Paul Stoffels with Lifetime Achievement Award at Annual
East/West CEO Conference
9:49 a.m. Jan. 14, 2014
- BusinessWire - BZX

ShangPharma Appoints Pharmaceutical Executive Dr. Mitchell Reff Chief Biologics Officer
9:10 a.m. Jan. 13, 2014
- PR Newswire - PRF

RBCC Partner n3D Commercializes New 3D Bioprinting Technology
5:53 a.m. Jan. 13, 2014
- BusinessWire - BZX

Sangamo BioSciences Announces Conference Call And Webcast To Discuss Global Collaboration with Biogen Idec to Develop Treatments for Hemoglobinopathies
7:10 a.m. Jan. 9, 2014
- PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Leapora's Taskeen: Redefining Task Accountability

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Compass Unveiled: Power Revolution in Private Equity

AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...

Sean Trahan Joins Citrin Cooperman: New Tax Lead

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

FJBio Boosts Antibody Discovery with Sapio AI

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

The Chemical Industry and EPA: A Broken System?

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Dr. Desi Bartlett Teams Up with Glo for Perimenopause Focus

Glo Taps Top Wellness Expert for Women's Health Initiative In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and...

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...